NCT04305054 · Interventional trial
Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02)
Overall registry status Completed
Phase 1 · Phase 2
Conditions Melanoma
Delaware Valley sites
- University of Pennsylvania Abramson Cancer Center ( Site 2008) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory